Literature DB >> 24320510

Measuring uncertainty in dose delivered to the cochlea due to setup error during external beam treatment of patients with cancer of the head and neck.

M Yan1, D Lovelock, M Hunt, J Mechalakos, Y Hu, H Pham, A Jackson.   

Abstract

PURPOSE: To use Cone Beam CT scans obtained just prior to treatments of head and neck cancer patients to measure the setup error and cumulative dose uncertainty of the cochlea.
METHODS: Data from 10 head and neck patients with 10 planning CTs and 52 Cone Beam CTs taken at time of treatment were used in this study. Patients were treated with conventional fractionation using an IMRT dose painting technique, most with 33 fractions. Weekly radiographic imaging was used to correct the patient setup. The authors used rigid registration of the planning CT and Cone Beam CT scans to find the translational and rotational setup errors, and the spatial setup errors of the cochlea. The planning CT was rotated and translated such that the cochlea positions match those seen in the cone beam scans, cochlea doses were recalculated and fractional doses accumulated. Uncertainties in the positions and cumulative doses of the cochlea were calculated with and without setup adjustments from radiographic imaging.
RESULTS: The mean setup error of the cochlea was 0.04 ± 0.33 or 0.06 ± 0.43 cm for RL, 0.09 ± 0.27 or 0.07 ± 0.48 cm for AP, and 0.00 ± 0.21 or -0.24 ± 0.45 cm for SI with and without radiographic imaging, respectively. Setup with radiographic imaging reduced the standard deviation of the setup error by roughly 1-2 mm. The uncertainty of the cochlea dose depends on the treatment plan and the relative positions of the cochlea and target volumes. Combining results for the left and right cochlea, the authors found the accumulated uncertainty of the cochlea dose per fraction was 4.82 (0.39-16.8) cGy, or 10.1 (0.8-32.4) cGy, with and without radiographic imaging, respectively; the percentage uncertainties relative to the planned doses were 4.32% (0.28%-9.06%) and 10.2% (0.7%-63.6%), respectively.
CONCLUSIONS: Patient setup error introduces uncertainty in the position of the cochlea during radiation treatment. With the assistance of radiographic imaging during setup, the standard deviation of setup error reduced by 31%, 42%, and 54% in RL, AP, and SI direction, respectively, and consequently, the uncertainty of the mean dose to cochlea reduced more than 50%. The authors estimate that the effects of these uncertainties on the probability of hearing loss for an individual patient could be as large as 10%.

Entities:  

Mesh:

Year:  2013        PMID: 24320510      PMCID: PMC3855099          DOI: 10.1118/1.4830427

Source DB:  PubMed          Journal:  Med Phys        ISSN: 0094-2405            Impact factor:   4.071


  11 in total

1.  Monte Carlo evaluation of 6 MV intensity modulated radiotherapy plans for head and neck and lung treatments.

Authors:  Lu Wang; Ellen Yorke; Chen-Shou Chui
Journal:  Med Phys       Date:  2002-11       Impact factor: 4.071

Review 2.  Radiation therapy and hearing loss.

Authors:  Niranjan Bhandare; Andrew Jackson; Avraham Eisbruch; Charlie C Pan; John C Flickinger; Patrick Antonelli; William M Mendenhall
Journal:  Int J Radiat Oncol Biol Phys       Date:  2010-03-01       Impact factor: 7.038

3.  Multiple regions-of-interest analysis of setup uncertainties for head-and-neck cancer radiotherapy.

Authors:  Lifei Zhang; Adam S Garden; Justin Lo; K Kian Ang; Anesa Ahamad; William H Morrison; David I Rosenthal; Mark S Chambers; X Ronald Zhu; Radhe Mohan; Lei Dong
Journal:  Int J Radiat Oncol Biol Phys       Date:  2006-04-01       Impact factor: 7.038

4.  Sensori-neural hearing loss after radiotherapy for nasopharyngeal carcinoma: individualized risk estimation.

Authors:  Henriette B Honoré; Søren M Bentzen; Kitty Møller; Cai Grau
Journal:  Radiother Oncol       Date:  2002-10       Impact factor: 6.280

5.  Sensorineural hearing loss in patients treated for nasopharyngeal carcinoma: a prospective study of the effect of radiation and cisplatin treatment.

Authors:  D L Kwong; W I Wei; J S Sham; W K Ho; P W Yuen; D T Chua; D K Au; P M Wu; D T Choy
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-09-01       Impact factor: 7.038

6.  Permanent unilateral hearing loss after radiotherapy for parotid gland tumors.

Authors:  Lisa van der Putten; Remco de Bree; John T Plukker; Johannes A Langendijk; Cas Smits; Fred R Burlage; C René Leemans
Journal:  Head Neck       Date:  2006-10       Impact factor: 3.147

7.  Sensorineural hearing loss in combined modality treatment of nasopharyngeal carcinoma.

Authors:  William C Chen; Andrew Jackson; Amy S Budnick; David G Pfister; Dennis H Kraus; Margie A Hunt; Hilda Stambuk; Sabine Levegrun; Suzanne L Wolden
Journal:  Cancer       Date:  2006-02-15       Impact factor: 6.860

Review 8.  Radiotherapy-induced ear toxicity.

Authors:  Barbara A Jereczek-Fossa; Andrzej Zarowski; Franco Milani; Roberto Orecchia
Journal:  Cancer Treat Rev       Date:  2003-10       Impact factor: 12.111

9.  Sensory neural hearing loss after concurrent cisplatin and radiation therapy for nasopharyngeal carcinoma.

Authors:  Young-Taek Oh; Chul-Ho Kim; Jin-Hyuk Choi; Seung-Hee Kang; Mison Chun
Journal:  Radiother Oncol       Date:  2004-07       Impact factor: 6.280

10.  Using an onboard kilovoltage imager to measure setup deviation in intensity-modulated radiation therapy for head-and-neck patients.

Authors:  James G Mechalakos; Margie A Hunt; Nancy Y Lee; Linda X Hong; C Clifton Ling; Howard I Amols
Journal:  J Appl Clin Med Phys       Date:  2007-09-24       Impact factor: 2.102

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.